Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. It enhances gamma-aminobutyric acid (GABA)ergic neurotransmission.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (acute treatment)
* Sedation (pre-procedural, ICU settings)
* Management of acute alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** Typically 1-4 mg orally or IM divided into 2-3 doses daily. Maximum recommended daily dose is generally 10 mg.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV/IM, may repeat after 10-20 minutes if needed. Maximum dose 8 mg. Intramuscular administration may be preferred if IV access is difficult.
* **Pre-procedural Sedation:** 2-4 mg IM or IV 15-30 minutes before a procedure.
* **ICU Sedation:** Titration based on patient response, often starting at 0.02-0.04 mg/kg/hour IV infusion.
* **Acute Alcohol Withdrawal:** 2-4 mg orally or IM every 4-6 hours as needed.
## Pediatric Dosing
* **Status Epilepticus:** 0.1 mg/kg IV/IM, not to exceed 4 mg per dose. May be repeated after 10-20 minutes. Maximum dose is 8 mg.
* **Anxiety/Sedation:** Dosing is highly variable and depends on indication and patient factors. Consultation with a pediatric specialist is recommended. Limited data for other indications.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution, may require reduced dosage.
* **Renal Impairment:** No specific adjustment is usually needed, but use with caution.
* **Elderly:** Initiate at the lower end of the adult dose range and titrate cautiously due to increased sensitivity and risk of side effects.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Myasthenia gravis.
* Sleep apnea.
## Adverse Effects
* **Common:** Sedation, dizziness, weakness, ataxia, confusion.
* **Serious:** Respiratory depression, paradoxical reactions (agitation, hallucinations), anterograde amnesia, dependence and withdrawal symptoms with prolonged use, hypotension (especially with rapid IV administration).
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, other sedatives/hypnotics, antihistamines):** Additive CNS depression, increased risk of sedation, respiratory depression, and death.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase lorazepam levels.
## Monitoring
* Level of consciousness and sedation.
* Respiratory rate and depth.
* Blood pressure.
* Signs of paradoxical reactions.
* Signs of dependence and withdrawal if used long-term or upon discontinuation.
## Clinical Pearls
* Intravenous administration should be slow to minimize risk of respiratory depression and hypotension.
* Avoid concurrent use with opioids due to risk of severe sedation, respiratory depression, and death.
* Long-term use can lead to physical and psychological dependence. Taper gradually upon discontinuation.
* For status epilepticus, IM administration may be as effective as IV and can be used if IV access is not readily available.
---
***Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for definitive guidance. Dosing may vary based on local protocols and individual patient factors.*
